Peter Belden, President of ICS, an AmerisourceBergen company
In this episode, Pete Belden talks about the role of third-party logistics in the commercialization process, how manufactures should solve challenges using 3PL partners, and where 3PL services are headed in the future.
Dr. Kate Perry, Director of Behavioral Science, Atlantis Healthcare
Dr. Perry discusses the complexities of self-management across chronic disease. We explore the application of health psychology and the role of technology in helping pharma support patients to stay on track with their prescribed treatment.
Prithul Bom, MBA, RAC, ASQ-CSQE, Senior Director, Scientific Affairs, TA Leader for Medical Device & Diagnostics, Chiltern
Lisa Moore, PhD, RN, Senior Director, Scientific Affairs, TA Leader for Cardiovascular, Chiltern
In this episode, we talk about how smartphones intersect with medical devices, what makes an app a mobile medical app, why companies should include a mobile medical app with their Class II or Class III medical devices, why Human Factors and Usability Engineering are so impor … Read More »
Chiquita Brooks-LaSure, Managing Director, Manatt Health
Joel S. Ario, Managing Director, Manatt Health
The 2016 election will have a major impact on both federal and state healthcare policy. To be sure your organization is prepared for all the possibilities, it’s critical to understand the political dynamics that will be at play under each potential scenario—and what they wil … Read More »
Angie Wheeler, CEO, Cello Health Insight, Chicago
Jim McDermott, Vice President, Cello Health BioConsulting
John Howley, Managing Director, Cello Health Communications, US
In this episode, our panel of experts will talk about the state of the rare disease space, and how to succeed in this growing arena. There is also a related white paper on this topic, which you can download using the link at the bottom of this listing.
Chuck Reed, Group Vice President, Pharmacy Innovation & Solutions, AmerisourceBergen Drug Corporation
In this episode, Chuck Reed talks about the Elevate Provider Network, how it helps provide better patient care, and how it benefits other stakeholders in the prescription medicine ecosystem.
Michael Carlin, Vice President, TrialCard
In this episode, Michael Carlin of TrialCard discusses rare diseases and orphan drugs, and how life sciences companies can overcome the many business challenges associated with these types of disease states. There is also a related white paper entitled “No Patient Left Behin … Read More »
Troy Johnson, Senior Consultant Analytics, TrialCard Market Access Solutions
This podcast episode discusses some of the environmental factors reinforcing the importance of co-pay program optimization and goes into detail on the various aspects of the program that can be optimized and common results. A real-world example of a program optimization ana … Read More »
Johanna Skilling, EVP, Director of Planning, US, Ogilvy CommonHealth Worldwide
The World Economic Forum has named collaboration as the key to global growth: public-private partnerships between companies large and small, NGOs, government agencies and academia are the single largest corporate trend of the decade. And why? The world’s problems are increas … Read More »
Fred Petito, Chief Behavioral and Engagement Officer, Guidemark Health
In this episode, Mr. Petito defines behavioral insights,and provides examples and case studies of how behavioral insights can be used in healthcare marketing with providers and patients. Also, please download our related white paper on this subject, using the link at the bot … Read More »
Kathleen McConnell, RPh, MBA, Managing Director, Scifluent, Cello Health Communications
Jason McDonough, PhD, SVP Medical Strategy, Cello Health Communications
Incorporating HEOR evidence into oncology drug development pathways is no longer optional, but essential. In this session we identify the reasons for increased importance of demonstrating value in an oncology clinical setting, discuss the ways in which HEOR evidence is the b … Read More »
Paul Mannu, Master Practitioner, Behavioural Insights, Cello Health Insight
In this podcast, Mr. Mannu talks about the adoption rate for physicians regarding wearables and health apps, the consumer movement toward personal health technologies, and how the life sciences industry can participate in its growth.
Mark Engelhart, Chief Commercial Officer, ACM Global Central Laboratory
In this interview, Mark Engelhart offers an alternative approach to clinical trial testing that involves consulting with a central lab in matching clinical diagnostic endpoints to outcomes. Mark will also talk about the evolving role that central labs are playing in optimizi … Read More »
Marc Schwartz, Consultant and Multi-Channel Marketing Executive
In this episode, we’ll explore the intricacies of transforming the industry’s traditional approach to sales and marketing to one that creates excellent customer experiences for patients and healthcare professionals (HCPs). Today, customers’ needs are changing, they have grea … Read More »
Milton Pedraza, CEO, Luxury Institute
In this episode, we’ll discuss what pharma can learn from brands outside the industry that are focusing on the customer experience. Brands such as The Ritz-Carlton, The Four Seasons, and Starbucks have successfully embraced the customer experience and, as a result, have earn … Read More »
Cheryl Lubbert, President and CEO, Health Perspectives Group (center)
Jean McCoy, SVP, Strategy & Innovation, Health Advocacy Strategies (left)
Pam Garfield, SVP, Strategy & Innovation, Patient Health Perspectives (right)
In this episode, we’ll have a panel discussion with the heads of three of the four companies that make up the Health Perspectives Group, a family of companies that helps healthcare firms use shared values to infuse the patient perspective across their organizations to create … Read More »
Paul LeVine, Vice President, Analytic Services, TrialCard
In this episode, Paul LeVine talks about a shift toward focusing on outcomes and how the patient’s voice is changing healthcare. There’s also a related whitepaper on this topic, which may be downloaded from the link below.
Dr. Theodore Search, PharmD, Founder and CEO of Skipta
In this episode, we meet with Dr. Theodore Search, PharmD, Founder and CEO of Skipta. We talk about why Skipta was started. We discuss the move to a patient centric model in the industry, how this impacts the dynamics of online medical communities, and finally, measuring s … Read More »
Paul LeVine, Vice President, Analytic Services, TrialCard
In this episode, Paul LeVine talks about co-pay, patient affordability, and patient engagement. There’s also a related whitepaper on this topic, which you can download from the link below.
Heather Gartman, Managing Director, inVentiv Health Public Relations Group Washington, D.C. operations
In this episode, Ms. Gartman discusses the findings from their recent research on Patient Advocacy Groups and their relationship with pharmaceutical companies. There is also a related white paper on this topic, now availablTe for download.
Tony Street, Director, Clinical Trial Supplies and Logistics, PAREXEL
In this interview, Tony Street addresses questions about the role of technology in a fully integrated clinical trial supply chain, from forecasting and proactive planning, to distribution to sites and patients, to final reconciliation. Tony will also talk about the current s … Read More »
Michael Griffith, Executive Vice President of inVentiv Health and President of inVentiv Commercial
Mark Archer, Global Head of Business Development of inVentiv Health
Old commercialization models are being redefined by new market realities, transforming the way biopharmaceutical companies need to do business. inVentiv Health has redefined Clinical and Commercial services to give biopharmaceutical companies a better way to create value. In … Read More »